Network meta-analysis of oral Chinese patent medicines for myocardial infarction with heart failure
Four Chinese medicines show promise for heart failure after heart attack
This network meta-analysis evaluated oral Chinese patent medicines combined with conventional treatment in patients with myocardial infarcti…
A network meta-analysis of 42 trials found four oral Chinese patent medicines improved outcomes when added to standard heart failure treatme…
MUSKARDIA shows protective trend in stable CAD with reduced eGFR
This Heart Pill from Traditional Medicine Shows Surprising Kidney Protection
A subgroup analysis of a phase IV trial found MUSKARDIA may protect against cardiovascular events in stable CAD patients with reduced kidney…
A traditional Chinese medicine pill already used for heart disease may also shield the kidneys, offering new hope for millions with both con…